Other Species / Isoforms
  CCDC50 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S5-p
___MAEVsIDQSKLP
Upstream
0 4
Treatment
  • ischemia
CCDC50 (human) ___MAEVsIDQSKLP S5-p
CCDC50 iso2 (human) ___MAEVSIDQSKLP S5
CCDC50 (mouse) ___MADVSVDQSKLP S5
CCDC50 iso2 (mouse) ___MADVSVDQSKLP S5
CCDC50 (rat) ___MADVSVDQSKLP S5
K15
QSKLPGVKEVCRDFA
0 1
CCDC50 (human) QSKLPGVKEVCRDFA K15
CCDC50 iso2 (human) QSKLPGVKEVCRDFA K15
CCDC50 (mouse) QSKLPGVkEVCRDFA K15-ub
CCDC50 iso2 (mouse) QSKLPGVKEVCRDFA K15
CCDC50 (rat) QSKLPGVKEVCRDFA K15
S32-p
EDHTLAHsLQEQEIE
0 4
CCDC50 (human) EDHTLAHsLQEQEIE S32-p
CCDC50 iso2 (human) EDHTLAHSLQEQEIE S32
CCDC50 (mouse) EDHTLAHsLQEQEIE S32-p
CCDC50 iso2 (mouse) EDHTLAHSLQEQEIE S32
CCDC50 (rat) EDHTLAHSLQEQEIE S32
K60-ub
QHDLQVAkQLQEEDL
0 3
CCDC50 (human) QHDLQVAkQLQEEDL K60-ub
CCDC50 iso2 (human) QHDLQVAKQLQEEDL K60
CCDC50 (mouse) QHDLQVAkQLQEEDL K60-ub
CCDC50 iso2 (mouse) QHDLQVAKQLQEEDL K60
CCDC50 (rat) QHDLQVAKQLQEEDL K60
K68-ub
QLQEEDLkAQAQLQk
0 6
CCDC50 (human) QLQEEDLkAQAQLQk K68-ub
CCDC50 iso2 (human) QLQEEDLKAQAQLQK K68
CCDC50 (mouse) QLQEEDLkAQAQLQK K68-ub
CCDC50 iso2 (mouse) QLQEEDLKAQAQLQK K68
CCDC50 (rat) QLQEEDLKAQAQLQK K68
K75-ub
kAQAQLQkRYkDLEQ
0 1
CCDC50 (human) kAQAQLQkRYkDLEQ K75-ub
CCDC50 iso2 (human) KAQAQLQKRYKDLEQ K75
CCDC50 (mouse) kAQAQLQKRYkALEQ K75
CCDC50 iso2 (mouse) KAQAQLQKRYKALEQ K75
CCDC50 (rat) KAQAQLQKRYKALEQ K75
K78-ub
AQLQkRYkDLEQQDC
0 2
CCDC50 (human) AQLQkRYkDLEQQDC K78-ub
CCDC50 iso2 (human) AQLQKRYKDLEQQDC K78
CCDC50 (mouse) AQLQKRYkALEQHDC K78-ub
CCDC50 iso2 (mouse) AQLQKRYKALEQHDC K78
CCDC50 (rat) AQLQKRYKALEQHDC K78
K94-ub
IAQEIQEkLAIEAER
0 4
CCDC50 (human) IAQEIQEkLAIEAER K94-ub
CCDC50 iso2 (human) IAQEIQEKLAIEAER K94
CCDC50 (mouse) IAQEIQEkLTIEAER K94-ub
CCDC50 iso2 (mouse) IAQEIQEKLTIEAER K94
CCDC50 (rat) IAQEIQEKLTIEAER K94
K107-ub
ERRRIQEkkDEDIAR
0 1
CCDC50 (human) ERRRIQEkkDEDIAR K107-ub
CCDC50 iso2 (human) ERRRIQEKKDEDIAR K107
CCDC50 (mouse) ERRRIQEKKDEDIAR K107
CCDC50 iso2 (mouse) ERRRIQEKKDEDIAR K107
CCDC50 (rat) ERRRIQEKKDEDIAR K107
K108-ub
RRRIQEkkDEDIARL
0 3
CCDC50 (human) RRRIQEkkDEDIARL K108-ub
CCDC50 iso2 (human) RRRIQEKKDEDIARL K108
CCDC50 (mouse) RRRIQEKKDEDIARL K108
CCDC50 iso2 (mouse) RRRIQEKKDEDIARL K108
CCDC50 (rat) RRRIQEKKDEDIARL K108
K119-ub
IARLLQEkELQEEKK
0 14
CCDC50 (human) IARLLQEkELQEEKK K119-ub
CCDC50 iso2 (human) IARLLQEKELQEEKK K119
CCDC50 (mouse) IARLLQEkELQEEKR K119-ub
CCDC50 iso2 (mouse) IARLLQEKELQEEKR K119
CCDC50 (rat) IARLLQEKELQEEKK K119
K128-ub
LQEEKKRkkHFPEFP
0 5
CCDC50 (human) LQEEKKRkkHFPEFP K128-ub
CCDC50 iso2 (human) LQEEKKRKKHFPEFP K128
CCDC50 (mouse) LQEEKRRKkHTPEFS K128
CCDC50 iso2 (mouse) LQEEKRRKKHTPEFS K128
CCDC50 (rat) LQEEKKRKKHTPEFS K128
K129-ub
QEEKKRkkHFPEFPA
Upstream
1 55
Treatment
  • EGF
CCDC50 (human) QEEKKRkkHFPEFPA K129-ub
CCDC50 iso2 (human) QEEKKRKKHFPEFPA K129
CCDC50 (mouse) QEEKRRKkHTPEFSG K129-ub
CCDC50 iso2 (mouse) QEEKRRKKHTPEFSG K129
CCDC50 (rat) QEEKKRKKHTPEFSG K129
Y140-p
EFPATRAyADsyyyE
Upstream
0 11
Treatment
  • EGF
CCDC50 (human) EFPATRAyADsyyyE Y140-p
CCDC50 iso2 (human) EFPATRAyADSyyYE Y140-p
CCDC50 (mouse) EFSGGSVFGDNYYHE F140
CCDC50 iso2 (mouse) EFSGGSVFGDNYYHE F140
CCDC50 (rat) EFSGGSASGDNYYYE S140
S143-p
ATRAyADsyyyEDGG
0 1
CCDC50 (human) ATRAyADsyyyEDGG S143-p
CCDC50 iso2 (human) ATRAyADSyyYEDGD S143
CCDC50 (mouse) GGSVFGDNYYHEDGG N143
CCDC50 iso2 (mouse) GGSVFGDNYYHEDGG N143
CCDC50 (rat) GGSASGDNYYYEDGG N143
Y144-p
TRAyADsyyyEDGGM
Upstream
0 39
Regulatory protein:
  • EGFR (human)
Treatment
  • ephrin_B1
  • PD173074
CCDC50 (human) TRAyADsyyyEDGGM Y144-p
CCDC50 iso2 (human) TRAyADSyyYEDGDQ Y144-p
CCDC50 (mouse) GSVFGDNYYHEDGGM Y144
CCDC50 iso2 (mouse) GSVFGDNYYHEDGGM Y144
CCDC50 (rat) GSASGDNYYYEDGGM Y144
Y145-p
RAyADsyyyEDGGMk
Upstream
Downstream
1 32
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • EGF
  • ephrin_B1
  • HGF
view more >
CCDC50 (human) RAyADsyyyEDGGMk Y145-p
CCDC50 iso2 (human) RAyADSyyYEDGDQP Y145-p
CCDC50 (mouse) SVFGDNYYHEDGGMk Y145
CCDC50 iso2 (mouse) SVFGDNYYHEDGGMK Y145
CCDC50 (rat) SASGDNYYYEDGGMK Y145
Y146-p
AyADsyyyEDGGMkP
Upstream
Downstream
1 23
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • antibody
  • EGF
  • ephrin_B1
  • ibrutinib
view more >
CCDC50 (human) AyADsyyyEDGGMkP Y146-p
CCDC50 iso2 (human) AyADSyyYEDGDQPG Y146
CCDC50 (mouse) VFGDNYYHEDGGMkP H146
CCDC50 iso2 (mouse) VFGDNYYHEDGGMKP H146
CCDC50 (rat) ASGDNYYYEDGGMKS Y146
-
gap
0 1
CCDC50 (human) gap -
CCDC50 iso2 (human) EDGDQPGsRRARELG S154-p
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
-
gap
0 1
CCDC50 (human) gap -
CCDC50 iso2 (human) PEQHCSSkRsLSSSS K201-ub
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
-
gap
0 7
CCDC50 (human) gap -
CCDC50 iso2 (human) QHCSSkRsLSSSSsG S203-p
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
-
gap
0 5
CCDC50 (human) gap -
CCDC50 iso2 (human) RsLSSSSsGKGRDNP S209-p
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
-
gap
0 2
CCDC50 (human) gap -
CCDC50 iso2 (human) SRHQDRLsPKSsQKA S276-p
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
-
gap
0 1
CCDC50 (human) gap -
CCDC50 iso2 (human) DRLsPKSsQKAGLHC S280-p
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
-
gap
0 3
CCDC50 (human) gap -
CCDC50 iso2 (human) LHCKEVVyGRDHGQG Y292-p
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
-
gap
0 14
CCDC50 (human) gap -
CCDC50 iso2 (human) KRRHRPRtPPFsESE T310-p
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
-
gap
0 1
CCDC50 (human) gap -
CCDC50 iso2 (human) RPRtPPFsESEEQLH S314-p
CCDC50 (mouse) gap -
CCDC50 iso2 (mouse) gap -
CCDC50 (rat) gap -
K152-ub
yyEDGGMkPRVMkEA
0 60
CCDC50 (human) yyEDGGMkPRVMkEA K152-ub
CCDC50 iso2 (human) HLHDAGMKPRVMKEA K328
CCDC50 (mouse) YHEDGGMkPRGIkEA K152-ub
CCDC50 iso2 (mouse) YHEDGGMKPRGIKEA K152
CCDC50 (rat) YYEDGGMKSRGINEA K152
K157-ub
GMkPRVMkEAVStPs
0 14
CCDC50 (human) GMkPRVMkEAVStPs K157-ub
CCDC50 iso2 (human) GMKPRVMKEAVSTPS K333
CCDC50 (mouse) GMkPRGIkEAVSTPA K157-ub
CCDC50 iso2 (mouse) GMKPRGIKEAVSTPA K157
CCDC50 (rat) GMKSRGINEAVSAPA N157
T162-p
VMkEAVStPsRMAHR
0 4
CCDC50 (human) VMkEAVStPsRMAHR T162-p
CCDC50 iso2 (human) VMKEAVSTPSRMAHR T338
CCDC50 (mouse) GIkEAVSTPARASHR T162
CCDC50 iso2 (mouse) GIKEAVSTPARASHR T162
CCDC50 (rat) GINEAVSAPARVSHR A162
S164-p
kEAVStPsRMAHRDQ
0 10
CCDC50 (human) kEAVStPsRMAHRDQ S164-p
CCDC50 iso2 (human) KEAVSTPSRMAHRDQ S340
CCDC50 (mouse) kEAVSTPARASHRDQ A164
CCDC50 iso2 (mouse) KEAVSTPARASHRDQ A164
CCDC50 (rat) NEAVSAPARVSHRDQ A164
Y174-p
AHRDQEWyDAEIARk
0 75
CCDC50 (human) AHRDQEWyDAEIARk Y174-p
CCDC50 iso2 (human) AHRDQEWYDAEIARK Y350
CCDC50 (mouse) SHRDQEWYDAEIARk Y174
CCDC50 iso2 (mouse) SHRDQEWYDAEIARk Y174
CCDC50 (rat) SHRDQEWYDAEIARK Y174
K181-ub
yDAEIARkLQEEELL
0 9
CCDC50 (human) yDAEIARkLQEEELL K181-ub
CCDC50 iso2 (human) YDAEIARKLQEEELL K357
CCDC50 (mouse) YDAEIARkLQEEELL K181-ub
CCDC50 iso2 (mouse) YDAEIARkLQEEELL K181-ub
CCDC50 (rat) YDAEIARKLQEEELL K181
K214-ub
RLLMAEEkKAykkAk
0 13
CCDC50 (human) RLLMAEEkKAykkAk K214-ub
CCDC50 iso2 (human) RLLMAEEKKAYKKAK K390
CCDC50 (mouse) RLLMAEEkKAYKKAK K214-ub
CCDC50 iso2 (mouse) RLLMAEEKKAYKKAK K199
CCDC50 (rat) RLLMAEEKKAYKKAK K214
Y217-p
MAEEkKAykkAkERE
Upstream
Downstream
1 0
Effects on Modified Protein
  • phosphorylation
Effects on Biological Processes:
  • apoptosis, inhibited
  • cell growth, altered
Putative in vivo kinases:
  • EGFR (human)
  • Lck (human)
Treatment
  • AG1478
  • EGF
CCDC50 (human) MAEEkKAykkAkERE Y217-p
CCDC50 iso2 (human) MAEEKKAYKKAKERE Y393
CCDC50 (mouse) MAEEkKAYKKAKERE Y217
CCDC50 iso2 (mouse) MAEEKKAYKKAKERE Y202
CCDC50 (rat) MAEEKKAYKKAKDRE Y217
K218-ac
AEEkKAykkAkEREk
0 1
CCDC50 (human) AEEkKAykkAkEREk K218-ac
CCDC50 iso2 (human) AEEKKAYKKAKEREK K394
CCDC50 (mouse) AEEkKAYKKAKEREk K218
CCDC50 iso2 (mouse) AEEKKAYKKAKEREK K203
CCDC50 (rat) AEEKKAYKKAKDREK K218
K219-ac
EEkKAykkAkEREkS
0 1
CCDC50 (human) EEkKAykkAkEREkS K219-ac
CCDC50 iso2 (human) EEKKAYKKAKEREKS K395
CCDC50 (mouse) EEkKAYKKAKEREkS K219
CCDC50 iso2 (mouse) EEKKAYKKAKEREKS K204
CCDC50 (rat) EEKKAYKKAKDREKS K219
K221-ac
kKAykkAkEREkSSL
0 1
CCDC50 (human) kKAykkAkEREkSSL K221-ac
CCDC50 iso2 (human) KKAYKKAKEREKSSL K397
CCDC50 (mouse) kKAYKKAKEREkSSL K221
CCDC50 iso2 (mouse) KKAYKKAKEREKSSL K206
CCDC50 (rat) KKAYKKAKDREKSSL K221
K225-ub
kkAkEREkSSLDKRk
0 5
CCDC50 (human) kkAkEREkSSLDKRk K225-ub
CCDC50 iso2 (human) KKAKEREKSSLDKRK K401
CCDC50 (mouse) KKAKEREkSSLDKRK K225-ub
CCDC50 iso2 (mouse) KKAKEREKSSLDKRK K210
CCDC50 (rat) KKAKDREKSSLDKRK K225
K232-ub
kSSLDKRkQDPEWkP
0 29
CCDC50 (human) kSSLDKRkQDPEWkP K232-ub
CCDC50 iso2 (human) KSSLDKRKQDPEWKP K408
CCDC50 (mouse) kSSLDKRKHDPECkL K232
CCDC50 iso2 (mouse) KSSLDKRKHDPECKL K217
CCDC50 (rat) KSSLDKRKHDYDCKS K232
K238-ub
RkQDPEWkPkTAkAA
0 6
CCDC50 (human) RkQDPEWkPkTAkAA K238-ub
CCDC50 iso2 (human) RKQDPEWKPKTAKAA K414
CCDC50 (mouse) RKHDPECkLKAKSAH K238-ub
CCDC50 iso2 (mouse) RKHDPECKLKAKSAH K223
CCDC50 (rat) RKHDYDCKSKAKSAH K238
K238-sm
RkQDPEWkPkTAkAA
0 1
CCDC50 (human) RkQDPEWkPkTAkAA K238-sm
CCDC50 iso2 (human) RKQDPEWKPKTAKAA K414
CCDC50 (mouse) RKHDPECKLKAKSAH K238
CCDC50 iso2 (mouse) RKHDPECKLKAKSAH K223
CCDC50 (rat) RKHDYDCKSKAKSAH K238
K240-ub
QDPEWkPkTAkAANS
0 6
CCDC50 (human) QDPEWkPkTAkAANS K240-ub
CCDC50 iso2 (human) QDPEWKPKTAKAANS K416
CCDC50 (mouse) HDPECkLKAKSAHSK K240
CCDC50 iso2 (mouse) HDPECKLKAKSAHSK K225
CCDC50 (rat) HDYDCKSKAKSAHSK K240
K243-ub
EWkPkTAkAANSKSk
0 2
CCDC50 (human) EWkPkTAkAANSKSk K243-ub
CCDC50 iso2 (human) EWKPKTAKAANSKSK K419
CCDC50 (mouse) PECkLKAKSAHSKSK K242
CCDC50 iso2 (mouse) PECKLKAKSAHSKSK K227
CCDC50 (rat) YDCKSKAKSAHSKSK K242
K250-ub
kAANSKSkESDEPHH
0 3
CCDC50 (human) kAANSKSkESDEPHH K250-ub
CCDC50 iso2 (human) KAANSKSKESDEPHH K426
CCDC50 (mouse) KSAHSKSKEGDEAHR K249
CCDC50 iso2 (mouse) KSAHSKSKEGDEAHR K234
CCDC50 (rat) KSAHSKSKEGDETQR K249
K259-ub
SDEPHHSkNERPARP
0 1
CCDC50 (human) SDEPHHSkNERPARP K259-ub
CCDC50 iso2 (human) SDEPHHSKNERPARP K435
CCDC50 (mouse) GDEAHRSKIDRPSRP K258
CCDC50 iso2 (mouse) GDEAHRSKIDRPSRP K243
CCDC50 (rat) GDETQRAKIDRPSRP K258
T272-p
RPPPPIMtDGEDADy
0 2
CCDC50 (human) RPPPPIMtDGEDADy T272-p
CCDC50 iso2 (human) RPPPPIMTDGEDADY T448
CCDC50 (mouse) RPPPPTMMGLEDTDP M271
CCDC50 iso2 (mouse) RPPPPTMMGLEDTDP M256
CCDC50 (rat) RPPPPAAMAPEDVDP M271
Y279-p
tDGEDADytHFtNQQ
Upstream
Downstream
1 93
Effects on Modified Protein
  • phosphorylation
Effects on Biological Processes:
  • apoptosis, inhibited
  • cell growth, altered
Putative in vivo kinases:
  • EGFR (human)
  • Lck (human)
Treatment
  • AG1478
  • EGF
  • ephrin_B1
  • Su11274
view more >
CCDC50 (human) tDGEDADytHFtNQQ Y279-p
CCDC50 iso2 (human) TDGEDADYTHFTNQQ Y455
CCDC50 (mouse) MGLEDTDPTHFTNQH P278
CCDC50 iso2 (mouse) MGLEDTDPTHFTNQH P263
CCDC50 (rat) MAPEDVDPTHFTNQH P278
T280-p
DGEDADytHFtNQQS
0 15
CCDC50 (human) DGEDADytHFtNQQS T280-p
CCDC50 iso2 (human) DGEDADYTHFTNQQS T456
CCDC50 (mouse) GLEDTDPTHFTNQHS T279
CCDC50 iso2 (mouse) GLEDTDPTHFTNQHS T264
CCDC50 (rat) APEDVDPTHFTNQHS T279
T283-p
DADytHFtNQQSsTR
0 2
CCDC50 (human) DADytHFtNQQSsTR T283-p
CCDC50 iso2 (human) DADYTHFTNQQSSTR T459
CCDC50 (mouse) DTDPTHFTNQHSTTW T282
CCDC50 iso2 (mouse) DTDPTHFTNQHSTTW T267
CCDC50 (rat) DVDPTHFTNQHSNTR T282
S288-p
HFtNQQSsTRHFSkS
0 1
CCDC50 (human) HFtNQQSsTRHFSkS S288-p
CCDC50 iso2 (human) HFTNQQSSTRHFSKS S464
CCDC50 (mouse) HFTNQHSTTWHLPKS T287
CCDC50 iso2 (mouse) HFTNQHSTTWHLPKS T272
CCDC50 (rat) HFTNQHSNTRHFSKS N287
K294-ub
SsTRHFSkSESSHkG
0 3
CCDC50 (human) SsTRHFSkSESSHkG K294-ub
CCDC50 iso2 (human) SSTRHFSKSESSHKG K470
CCDC50 (mouse) STTWHLPKSESSQkG K293
CCDC50 iso2 (mouse) STTWHLPKSESSQKG K278
CCDC50 (rat) SNTRHFSKSESSHKG K293
K300-ub
SkSESSHkGFHyKH_
0 2
CCDC50 (human) SkSESSHkGFHyKH_ K300-ub
CCDC50 iso2 (human) SKSESSHKGFHYKH_ K476
CCDC50 (mouse) PKSESSQkGFHNKQ_ K299-ub
CCDC50 iso2 (mouse) PKSESSQKGFHNKQ_ K284
CCDC50 (rat) SKSESSHKGFHNKQ_ K299
Y304-p
SSHkGFHyKH_____
Upstream
Downstream
1 0
Effects on Modified Protein
  • phosphorylation
Effects on Biological Processes:
  • apoptosis, inhibited
  • cell growth, altered
Putative in vivo kinases:
  • EGFR (human)
  • Lck (human)
Treatment
  • AG1478
  • EGF
CCDC50 (human) SSHkGFHyKH_____ Y304-p
CCDC50 iso2 (human) SSHKGFHYKH_____ Y480
CCDC50 (mouse) SSQkGFHNKQ_____ N303
CCDC50 iso2 (mouse) SSQKGFHNKQ_____ N288
CCDC50 (rat) SSHKGFHNKQ_____ N303